{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:35:29Z","timestamp":1793910929255,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10815-022-02559-0","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T04:04:47Z","timestamp":1657166687000},"page":"1959-1965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Development of children born after in vitro maturation with a prematuration step versus natural conception: a prospective cohort study"],"prefix":"10.1007","volume":"39","author":[{"given":"Duy L.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toan D.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh H. N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan N.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"2559_CR1","doi-asserted-by":"publisher","first-page":"5750298","DOI":"10.1155\/2018\/5750298","volume":"2018","author":"S Julania","year":"2018","unstructured":"Julania S, Walls ML, Hart R. The place of in vitro maturation in PCO\/PCOS. Int J Endocrinol. 2018;2018:5750298.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2559_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejogrb.2012.07.001","volume":"165","author":"E Shalom-Paz","year":"2012","unstructured":"Shalom-Paz E, Holzer H, Son W, Levin I, Tan SL, Almog B. PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):53\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"2559_CR3","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/humrep\/dev125","volume":"30","author":"ML Walls","year":"2015","unstructured":"Walls ML, Ryan JP, Keelan JA, Hart R. In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts. Hum Reprod. 2015;30(8):1842\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"2559_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","volume":"55","author":"KY Cha","year":"1991","unstructured":"Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril. 1991;55(1):109\u201313.","journal-title":"Fertil Steril"},{"issue":"4","key":"2559_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5653\/cerm.2013.40.4.143","volume":"40","author":"KS Lim","year":"2013","unstructured":"Lim KS, Chae SJ, Choo CW, Ku YH, Lee HJ, Hur CY, et al. In vitro maturation: clinical applications. Clin Exp Reprod Med. 2013;40(4):143\u20137.","journal-title":"Clin Exp Reprod Med"},{"issue":"1","key":"2559_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/humupd\/dmg005","volume":"9","author":"A Delvigne","year":"2003","unstructured":"Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9(1):77\u201396.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2559_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5653\/cerm.2012.39.4.166","volume":"39","author":"MH Choi","year":"2012","unstructured":"Choi MH, Lee SH, Kim HO, Cha SH, Kim JY, Yang KM, et al. Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: in vitro maturation, GnRH agonist, and GnRH antagonist cycles. Clin Exp Reprod Med. 2012;39(4):166\u201371.","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"2559_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rbmo.2014.07.019","volume":"29","author":"M Das","year":"2014","unstructured":"Das M, Son WY, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online. 2014;29(5):545\u201351.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2559_CR9","first-page":"77","volume":"6","author":"A Ellenbogen","year":"2014","unstructured":"Ellenbogen A, Shavit T, Shalom-Paz E. IVM results are comparable and may have advantages over standard IVF. Facts Views Vis Obgyn. 2014;6(2):77\u201380.","journal-title":"Facts Views Vis Obgyn"},{"issue":"2","key":"2559_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","volume":"98","author":"AS Gremeau","year":"2012","unstructured":"Gremeau AS, Andreadis N, Fatum M, Craig J, Turner K, McVeigh E, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril. 2012;98(2):355\u201360.","journal-title":"Fertil Steril"},{"issue":"5","key":"2559_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.fertnstert.2016.03.013","volume":"105","author":"RJ Paulson","year":"2016","unstructured":"Paulson RJ, Fauser B, Vuong LTN, Doody K. Can we modify assisted reproductive technology practice to broaden reproductive care access? Fertil Steril. 2016;105(5):1138\u201343.","journal-title":"Fertil Steril"},{"issue":"2","key":"2559_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.fertnstert.2012.01.114","volume":"98","author":"L Guzman","year":"2012","unstructured":"Guzman L, Ortega-Hrepich C, Albuz FK, Verheyen G, Devroey P, Smitz J, et al. Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil Steril. 2012;98(2):503-507e1-2.","journal-title":"Fertil Steril."},{"issue":"9","key":"2559_CR13","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/humrep\/dez121","volume":"34","author":"MD Saenz-de-Juano","year":"2019","unstructured":"Saenz-de-Juano MD, Ivanova E, Romero S, Lolicato F, S\u00e1nchez F, Van Ranst H, et al. DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients. Hum Reprod. 2019;34(9):1640\u20139.","journal-title":"Hum Reprod"},{"issue":"10","key":"2559_CR14","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1093\/humrep\/dex262","volume":"32","author":"F S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez F, Lolicato F, Romero S, De Vos M, Van Ranst H, Verheyen G, et al. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield. Hum Reprod. 2017;32(10):2056\u201368.","journal-title":"Hum Reprod"},{"issue":"3","key":"2559_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1472-6483(10)61438-1","volume":"13","author":"WY Son","year":"2006","unstructured":"Son WY, Yoon SH, Lim JH. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online. 2006;13(3):340\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"2559_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/humrep\/deu248","volume":"30","author":"ML Walls","year":"2015","unstructured":"Walls ML, Hunter T, Ryan JP, Keelan JA, Nathan E, Hart RJ. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2015;30(1):88\u201396.","journal-title":"Hum Reprod"},{"issue":"9","key":"2559_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/molehr\/gax032","volume":"23","author":"NW Santiquet","year":"2017","unstructured":"Santiquet NW, Greene AF, Becker J, Barfield JP, Schoolcraft WB, Krisher RL. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence. Mol Hum Reprod. 2017;23(9):594\u2013606.","journal-title":"Mol Hum Reprod"},{"issue":"10","key":"2559_CR18","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s10815-019-01551-5","volume":"36","author":"F Sanchez","year":"2019","unstructured":"Sanchez F, Le AH, Ho VNA, Romero S, Van Ranst H, De Vos M, et al. Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles. J Assist Reprod Genet. 2019;36(10):2135\u201344.","journal-title":"J Assist Reprod Genet"},{"key":"2559_CR19","volume-title":"The ASQ-3 user\u2019s guide","author":"J Squires","year":"2009","unstructured":"Squires J, Twombly E, Bricker D, Potter L. The ASQ-3 user\u2019s guide. MD Brookes: Baltimore; 2009."},{"key":"2559_CR20","doi-asserted-by":"crossref","unstructured":"Scharf RJ, Scharf GJ, 2016 Stroustrup A. Developmental milestones. Pediatr Rev. 37(1):25\u201337; quiz 8, 47.","DOI":"10.1542\/pir.2014-0103"},{"issue":"10","key":"2559_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.earlhumdev.2006.01.012","volume":"82","author":"M Shu-Chi","year":"2006","unstructured":"Shu-Chi M, Jiann-Loung H, Yu-Hung L, Tseng-Chen S, Ming IL, Tsu-Fuh Y. Growth and development of children conceived by in-vitro maturation of human oocytes. Early Hum Dev. 2006;82(10):677\u201382.","journal-title":"Early Hum Dev"},{"key":"2559_CR22","doi-asserted-by":"crossref","unstructured":"Agarwal PK, Shi L, Daniel LM, Yang PH, Khoo PC, Quek BH et al. 2017 Prospective evaluation of the Ages and Stages Questionnaire 3rd Edition in very low birthweight infants .Dev Med Child Neurol 59 (5) 484-9","DOI":"10.1111\/dmcn.13307"},{"issue":"2","key":"2559_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170171","volume":"12","author":"R Mackin","year":"2017","unstructured":"Mackin R, Ben Fadel N, Feberova J, Murray L, Nair A, Kuehn S, et al. ASQ3 and\/or the Bayley-III to support clinicians\u2019 decision making. PLoS ONE. 2017;12(2): e0170171.","journal-title":"PLoS ONE"},{"issue":"4","key":"2559_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/01.AOG.0000284627.38540.80","volume":"110","author":"WM Buckett","year":"2007","unstructured":"Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol. 2007;110(4):885\u201391.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"2559_CR25","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1093\/humrep\/des359","volume":"27","author":"R Fadini","year":"2012","unstructured":"Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601\u20138.","journal-title":"Hum Reprod"},{"key":"2559_CR26","unstructured":"Belva F, Roelants M, Vermaning S, Desmyttere S, De Schepper J, Bonduelle M et al. Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome. Human Reproduction Open.\u00a02020;2020(1)."}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02559-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T03:23:23Z","timestamp":1661829803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02559-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2559"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02559-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lan N. Vuong has received speaker and conference fees from Merck; grant, speaker, and conference fees from Merck Sharpe and Dohme; and speaker and conference fees from Ferring. Duy\u00a0L. Nguyen, Nghia A. Nguyen, Toan D. Pham, and Minh H. N. Nguyen have no financial relationships with any organizations that might have an interest in the submitted work in the previous 3\u00a0years, and no other relationships or activities that could appear to have influenced the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}